Skip to main content
. 2018 Jan 19;13(1):e0191511. doi: 10.1371/journal.pone.0191511

Fig 2. TMZ treatment of non-CSCs leads to increased tumorigenicity in vitro which can be diminished by combination treatment with Dox.

Fig 2

Tumorigenicity of GBM cell lines after treatment with TMZ, Dox or a combination of both drugs in vitro, * p<0.05, *** p<0.001, Mann Whitney rank sum test.